Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinnarizine + dimenhydrinate versus betahistine for peripheral vertigo
2011-004025-27Phase 4Completed
- Sponsor
- Hennig Arzneimittel
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Peripheral vertigo comparing Fixed combination cinnarizine + dimenhydrinate with Betahistine comparator (2 arms). Primary endpoint: Change in Mean Vertigo Score from baseline to Week 4. Started Oct 2012; status: completed.
02
Drugs
cinnarizinedimenhydrinatebetahistine
03
Conditions
Peripheral vertigo
Beyond the preview
Go deeper on 2011-004025-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004025-27.